LSTA — Lisata Therapeutics Share News
0.000.00%
Last trade - 00:00- $30.60m
- $17.28m
- $0.17m
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal
NASDAQ RESUMED AT 07:30 AM
Brief: Lisata Therapeutics To Be Acquired By Kuva Labs For $4.00 Per Share In An All-Cash Tender Offer
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Lisata Therapeutics Q3 net loss narrows to $4.2 mln
Brief: Lisata Therapeutics Q3 EPS USD -0.49
Brief: Lisata Therapeutics And Catalent Announce Global Antibody-Drug Conjugate License Agreement
Brief: Lisata Therapeutics Announces Encouraging Preliminary Results From The Pancreatic Cancer Cohort
TotalEnergies CEO says NextDecade to announce FID on Rio Grande LNG train on Tuesday, CNBC reports (updated)
Lisata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
TotalEnergies won't invest in NextDecade’s Train 5 LNG project, sources say
Lisata Therapeutics Inc expected to post a loss of 65 cents a share - Earnings Preview
Lisata Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Lisata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview
Motor racing-Norris leads McLaren practice one-two as Tsunoda crashes (updated)
Brief: Lisata Therapeutics- Will Evaluate Efficacy Of Certepetide